PDF-Give Yourself a Biologic Tune-up: Rebalance the 7 Core Biologic System

GIVE YOURSELF A BIOLO 147I didn146t know how bad I was feeling until I started feeling better148hat is what my patients tell me every day They go from being ill or just okay to experiencing. a Virtual Biologics Clinic. Dr Ben Parker PhD, MRCP. Consultant Rheumatologist, Manchester Royal Infirmary. Honorary Senior Lecturer, University of Manchester. To cover. Why the need for innovation in biologics services?. Presented by . the Alliance for Safe Bioloigic . Medicines & the Global Colon Cancer Association. . . . . Andrew Spiegel, Esquire. . . andrew.spiegel@globalcca.org. THANK YOU! . H671. Krieger . (1994). Describes the metaphorical “web of causation” and the missing “spider”. Epidemiologic approach – bottom up, as opposed to top down. No theoretic foundation, thus true cause of disease not recognized. August, 2014. Biologics & Biosimilars: . An Overview. 1. What is a biologic?. 2. Biologics Are Complex. Biologics are innovative medications that aren’t made, they are grown in living cells. . Biologics are complex molecules– up to 1,000 times larger than conventional medicines. . Introduction. Case 1: When to Start a Biologic?. Case 1: When to Start a Biologic? (cont). Case 1: When to Start a Biologic? (cont). Case 1: When to Start a Biologic? (cont). Case 1: When to Start a Biologic? (cont). Objectives. Describe six key factors that compose the “chain of infection”. Identify clinical and epidemiologic clues suggestive of a biologic disaster. Discuss actions that can be taken to protect the health, safety, and security of responders and affected populations in a biologic disaster. Roger J. Packer, MD. Senior Vice-President Neuroscience and Behavioral Medicine. Director, Brain Tumor Institute. Children’s National Health System. Washington, DC. Welcome to CBTTC. CNHS honored to be a member. 1. DRUG NAMES. Chemical name. Development name used internally. Biologic drugs too complex to use chemical name. Non-proprietary name (generic name). Combination name for some combination drugs. Proprietary name (brand name). Crohn’s. Disease used for. :. Severe active CD: HBI = >8 CDAI = >300. Inadequate response for tolerance of contraindication to conventional therapies. Chronic active CD with failure to control with immunosuppression. . for. . Rheumatic. . Diseases. . in . Pregnancy. Yesim. . Garip, MD. Pinar. . Physical. . Therapy. . and. . Rehabilitation. Center. Ankara, . TURKEY. 1. The most common used biologic therapeutic agents . Universal Stool Bank. Patient-directed donor. GI. IBD, IBS, GVHD ICI Colitis. Potential Non-CDI Indications. Gupta S, . Mullish. BH, and . Allegretti. JR. . Am J Gastroenterol. 2020. . . FMT: The Evolving Risk Landscape. . presented by. . Dipali Balaji Waghmare (Intern) . BIOLOGIC CONSIDERATION. . . Associate Professor Nicole Pratt . Quality use of medicines and pharmacy research centre. University of South Australia. overview. Biologic medicines, or immune based therapies, are a rapidly evolving group of pharmaceutical products whose active component is biologically derived rather than chemically synthesised. . Learning Lunch. 2/15/19. Biomechanics?. What is the function of…. musculoskeletal tissues (bone, cartilage, tendon, etc)?. Biomechanics and the MS. To understand normal tissue and joint structure and function.